- Home
- SRZN vs NMT Comparison
SRZN vs NMT Comparison
Compare SRZN & NMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRZN
- NMT
- Stock Information
- Founded
- SRZN 2015
- NMT 1993
- Country
- SRZN United States
- NMT United States
- Employees
- SRZN N/A
- NMT N/A
- Industry
- SRZN Medicinal Chemicals and Botanical Products
- NMT Finance/Investors Services
- Sector
- SRZN Health Care
- NMT Finance
- Exchange
- SRZN Nasdaq
- NMT Nasdaq
- Market Cap
- SRZN 97.3M
- NMT 107.6M
- IPO Year
- SRZN N/A
- NMT N/A
- Fundamental
- Price
- SRZN $11.55
- NMT $11.61
- Analyst Decision
- SRZN Strong Buy
- NMT
- Analyst Count
- SRZN 2
- NMT 0
- Target Price
- SRZN $38.50
- NMT N/A
- AVG Volume (30 Days)
- SRZN 12.2K
- NMT 19.1K
- Earning Date
- SRZN 11-05-2025
- NMT 01-01-0001
- Dividend Yield
- SRZN N/A
- NMT 3.21%
- EPS Growth
- SRZN N/A
- NMT N/A
- EPS
- SRZN N/A
- NMT N/A
- Revenue
- SRZN $12,621,000.00
- NMT N/A
- Revenue This Year
- SRZN N/A
- NMT N/A
- Revenue Next Year
- SRZN N/A
- NMT N/A
- P/E Ratio
- SRZN N/A
- NMT N/A
- Revenue Growth
- SRZN N/A
- NMT N/A
- 52 Week Low
- SRZN $5.90
- NMT $9.05
- 52 Week High
- SRZN $18.17
- NMT $10.93
- Technical
- Relative Strength Index (RSI)
- SRZN 53.57
- NMT 61.76
- Support Level
- SRZN $11.25
- NMT $11.53
- Resistance Level
- SRZN $11.74
- NMT $11.58
- Average True Range (ATR)
- SRZN 0.59
- NMT 0.11
- MACD
- SRZN -0.13
- NMT 0.03
- Stochastic Oscillator
- SRZN 21.37
- NMT 87.00
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).
About NMT Nuveen Massachusetts Quality Municipal Income Fund
Nuveen Massachusetts Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's objective seeks to provide current income exempt from both regular federal and Massachusetts income taxes and to enhance portfolio value relative to the Massachusetts municipal bond market by investing in tax-exempt Massachusetts municipal obligations that are underrated or undervalued or that represent municipal market sectors that are undervalued.